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1  | INTRODUC TION
Intracranial arterial dolichoectasia (IADE), also called dilatative arte‐
riopathy of the brain vessels, is defined as an increase in the length 
and diameter of at least one intracranial artery.1 The prevalence of 
IADE is reported to be 0.1%‐6.5% in the general population2 and 
about 12% among stroke patients,3 with the basilar artery involved 
in most cases. IADE may be asymptomatic or associated with stroke, 
subarachnoid hemorrhage, cranial nerve palsy, midbrain compres‐
sion, or obstructive hydrocephalus.
To date, one of the most important observational studies 
focused on IADE is the Étude du Profil Génétique de l’Infarctus 
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Objectives: To investigate clinical and demographic characteristics of patients with 
intracranial arterial dolichoectasia (IADE) and describe the possible coexistence of 
cerebral small vessel disease (SVD) and systemic arteriopathy.
Material and methods: From January 2015 to March 2016, all the patients attending 
an outpatient service for chronic cerebrovascular diseases were screened for sus‐
pected IADE. Identified patients underwent a predefined protocol including: brain 
MR angiography for the diagnosis of IADE; brain MRI with visual rating of SVD fea‐
tures; whole‐body CT angiography to assess signs of systemic arteriopathy; and neu‐
ropsychological examination.
Results: Among the 251 patients screened, IADE was diagnosed in seven (mean 
age ± SD 68.8 ± 7.2 years, six males). Hypertension was the most frequent risk fac‐
tor. All patients had basilar artery dolichoectasia, two also ectasia of a vessel of the 
anterior circulation. All patients had white matter hyperintensities that were moder‐
ate or severe in six, five had at least one lacune, and all had enlarged perivascular 
spaces. At least one microbleed was detected in six patients. A variable grade of 
global cortical atrophy was found in six patients. Systemic arterial ectasia was found 
in all but one patient. Neuropsychological examination showed a multidomain cogni‐
tive impairment in five patients.
Conclusions: Our study confirms the high prevalence of cerebral SVD in IADE. The 
involvement of the brain‐supplying arteries is probably part of a systemic arteriopa‐
thy in IADE patients, thus suggesting the usefulness of assessing the whole arterial 
tree in clinical practice. Cognitive deterioration signs are frequent in these 
patients.
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Cérébral (GENIC Study), in which the possible association with 
the main features of cerebral small vessel disease (SVD) and with 
enlarged systemic arteries was explored.1 Investigators found 
that among 510 consecutive patients with brain infarct, those 
having IADE more often showed multilacunar state, severe leu‐
koaraiosis, and severe état criblé (enlarged perivascular spaces) 
on MRI.4 There was also a different distribution of stroke sub‐
types, being the lacunar stroke more frequent in patients with 
IADE than in patients without.3 A GENIC substudy showed that 
patients with IADE had larger descending thoracic aorta, support‐
ing the hypothesis of a systemic nature of the process underlying 
IADE.5 Similar evidence comes from a recent autopsy series in 
which a significant association between IADE and coronary ar‐
tery ectasia was found in stroke patients, suggesting a common 
pathogenesis.6
In the context of an outpatient cerebrovascular disease clinic, 
we performed a prospective assessment of a small series of IADE 
patients with the aims to assess: (a) the demographic and clinical 
characteristics, including neuropsychological testing; (b) the coex‐
istence of cerebral SVD; and (c) the presence of systemic vessel 
arteriopathy.
2  | MATERIAL AND METHODS
2.1 | Clinical setting and study structure
The study was conducted in accordance with the ethical principles 
of the Helsinki Declaration and involved outpatients referred to a 
clinic devoted to cerebrovascular diseases.7,8 Reasons for patient re‐
ferral were, in particular: disturbances associated with the presence 
of cerebrovascular lesions or a history of stroke such as memory 
complaints, diagnosis of cognitive decline, language deficits, mood 
disorders, gait disturbances of the apraxic type; finding of vascular 
lesions on neuroimaging known to be possibly related to cognitive 
impairment; and screening for hereditary forms of cerebrovascular 
diseases.
From January 1, 2015, to March 1, 2016, out of the 251 pa‐
tients attending the clinic, seven (2.8%) were assigned a presump‐
tive diagnosis of IADE using personal brain MRI based on the 
visual impression that the intracranial arteries were longer and 
wider than normal. Identified possible IADE patients underwent 
a protocol that included brain MR angiography to confirm the di‐
agnosis of IADE according to the criteria proposed by Smoker et 
al9 and by Passero and Rossi10; family and clinical history assess‐
ment, with particular focus on stroke and vascular risk factor pro‐
file; extensive neuropsychological assessment; brain MRI, with 
visual rating of SVD features; and whole‐body CT angiography 
to assess the presence of systemic arteriopathy. In accordance 
with usual clinical practice and based on the current diagnostic 
management, each patient underwent further instrumental and 
laboratory tests.
Informed consent was obtained from all the 251 patients.
2.2 | Brain MR angiography and MRI 
protocol and assessment
Brain MR angiography and MRI were performed using a Siemens 
1.5 T Magnetom Aera machine, with a maximum gradient amplitude 
of 35 mT/m and a slew rate of 200 mT m−1 ms.−1 The protocol in‐
cluded the following sequences: magnetization‐prepared rapid gradi‐
ent‐echo (MPRAGE) 3D T1‐weighed, axial fluid‐attenuated inversion 
recovery (FLAIR) turbo spin‐echo (TSE), axial T2‐weighted TSE, axial 
T2‐weighted gradient‐echo (GE) fast low angle shot (FLASH), axial 
echo‐planar diffusion‐weighted imaging (EP‐DWI), time‐of‐flight 
(TOF) MR angiography, and MR angiography with maximum inten‐
sity projection (MIP) multiplanar reconstructions. Two neurologists 
experienced in brain imaging assessment (FF and AP) reviewed all 
the available scans and assessed the following parameters: (a) pres‐
ence of one or more dolichoectatic arteries, assessed by means of 
objective criteria proposed by Smoker et al9 for basilar dolichoecta‐
sia (elongation indicated by the invasion of the dorsum sellae margin 
or by a bifurcation height located over the suprasellar cistern plane; 
ectasia indicated by a diameter cutoff >4.5 mm as measured on TOF 
MR angiography sequences) and by Passero and Rossi10 for vessels 
other than basilar artery (ectasia indicated by diameter cutoffs for 
the internal carotid artery ≥7 mm, middle cerebral artery ≥4 mm, and 
vertebral artery ≥4 mm, as measured on TOF sequences); (b) pres‐
ence and severity of leukoencephalopathy (white matter hyperin‐
tensities on FLAIR or T2‐weighted images) assessed by the modified 
Fazekas visual scale,11 classifying all patients into three groups ac‐
cording to the grade of deep and subcortical white matter hyperin‐
tensity severity (grade 1, mild white matter hyperintensities: single 
lesions <10 mm, or areas of “grouped” lesions <20 mm in any diam‐
eter; grade 2, moderate white matter hyperintensities: single hyper‐
intense lesions between 10 and 20 mm, or areas of “grouped” lesions 
≥20 mm in any diameter, no more than “connecting bridges” between 
individual lesions; and grade 3, severe white matter hyperintensities: 
single lesions or confluent areas of hyperintensity ≥20 mm in any di‐
ameter); (c) presence and number of lacunes of presumed vascular 
origin, defined as focal hyperintensities on T2‐weighted TSE images, 
3 mm in size or larger, and with a corresponding hypointensity on T1‐
weighted images,12 dividing patients into three groups according to 
the lacunes number (0, 1‐3, or >3 lacunes); (d) number and location of 
enlarged perivascular spaces, defined as small (<3 mm wide), sharply 
delineated structures of cerebrospinal fluid intensity on T1‐weighted 
images that follow the orientation of the perforating vessels and run 
perpendicular to the brain surface, dividing patients into five groups 
by means of the 5‐point scale proposed by Doubal et al13 (0 = 0, 
1 = <10, 2 = 11‐20, 3 = 21‐40, and 4 = >40, separated count for basal 
ganglia and semioval centrum; the numbers refer to enlarged perivas‐
cular spaces on one side of the brain; the higher score was used if 
there was asymmetry between the sides and enlarged perivascu‐
lar spaces were counted in the slice with the highest number; basal 
ganglia and centrum semiovale enlarged perivascular spaces scores 
were summed to form a total score, 0 to 8); (e) number and location 
of microbleeds, defined as small, rounded or circular, well‐defined 
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hypointense lesions with clear margins ranging from 2 to 10 mm in 
size on T2‐weighted GE images, using the Microbleed Anatomical 
Rating Scale14; and (f) presence of global cortical atrophy, defined as 
a brain volume reduction that is not related to a specific macroscopic 
focal injury such as trauma or infarct, and classified into four groups 
(absent, mild, moderate, severe) by means of the Pasquier scale.15
The assessment of neuroimaging SVD features was also per‐
formed in patients not suspected of IADE using available images. 
The presence of SVD was defined as a modified Fazekas scale score 
≥2 or =1 plus one or more lacune.
2.3 | Whole‐body CT angiography 
protocol and assessment
Systemic arteries CT angiography was performed using the Siemens 
SOMATOM Definition Flash machine, Dual Source technology, CARE 
platform, based on FLASH acquisition technique. The protocol in‐
cluded the following parameters: tomogram length 1970 mm, collima‐
tion 128 × 0.6 mm, spatial resolution 0.3 mm, scan time <0.2 second, 
rotation time 0.28 second, tube settings 120 kV, 426 mAs, and effi‐
cacious dose 3.7 mSv. Axial 0.6 mm thick images were obtained and 
processed using the syngo.via software. The Iomeron 400 mg/mL 
Bracco contrast medium was administered by means of an automatic 
injector with a dosage of 100 mL (infusion speed 5.0 mL/s) prior pre‐
Monitor scansion with a 150 UH threshold on the ascending aorta. 
The presence of atheromatous intimal thickening, ectasia, stenosis, 
and endoluminal occlusion was extensively investigated. Normative 
reference diameters were the following, for each major arterial dis‐
trict: aortic bulb 38‐40 mm and ascending aorta 40 mm (adjusted for 
age and gender), aortic arch 35 mm, descending aorta 28‐30 mm, su‐
prarenal abdominal aorta 25 mm, subrenal abdominal aorta 20 mm, 
common iliac artery 15 mm, internal iliac artery 8 mm, external iliac 
artery 8‐10 mm, femoral artery 6‐8 mm, and popliteal artery 4‐6 mm.
2.4 | Cognitive function assessment
Cognitive global efficiency was assessed by means of the Mini‐
Mental State Examination. Verbal memory was assessed by 
means of the Rey Auditory‐Verbal Learning Test, a tool that in‐
cludes an immediate and delayed recall after 15 minutes. In both 
tasks, the score was the total number of recalled words. Focalized 
and maintained attention was assessed by means of the Symbol 
Digit Modalities Test and a Visual Search test. The Symbol Digit 
Modalities Test is a symbol substitution task and assesses complex 
scanning and visual tracking. The Visual Search test requires visual 
selectivity at fast speed and assesses the capacity for sustained 
attention and accuracy of visual scanning. Divided and selective 
attention was assessed by means of the Trail Making Test and 
Color Word Stroop Test. The Trail Making Test is a test of complex 
visual scanning and divided attention and has an important motor 
speed component. The Color Word Stroop Test is a measure of 
concentration effectiveness and deals with response inhibition 
and selective attention. Finally, language was assessed by means 
of phonemic (P‐F‐L) and semantic (animals‐fruits‐cars) verbal flu‐
ency tests. For both tests, the final score was the total number of 
words produced.
2.5 | Genetic assessment
Based on clinical and neuroimaging features, three patients fit crite‐
ria for suspected Cerebral Autosomal Dominant Arteriopathy with 
Subcortical Infarcts and Leukoencephalopathy (CADASIL)16 and 
thus underwent genetic examination of the NOTCH3 gene (19p13). 
Because Fabry disease is an inherited disorder that has been re‐
ported in association with IADE, all the male patients were subjected 
to venous blood sampling for the assessment of blood level of alpha‐
galactosidase activity, while in the female patient, a sequencing of 
the GLA gene (Xq22) was performed.
3  | RESULTS
A diagnosis of IADE was confirmed by consensus between two 
neurologists in all seven suspected patients. All patients had doli‐
choectasia of the basilar artery (mean diameter at midpons ± SD 
6.9 ± 3.6 mm), one also with carotid siphon ectasia, and one with 
carotid siphon and middle cerebral artery ectasia (Figure 1A and 2).
The demographical characteristics and the vascular risk factor 
profile of the IADE and non‐IADE patients are reported in Table 1. 
Among IADE patients, a personal history of stroke was reported in 
five cases. In particular, one suffered from a stroke due to a parame‐
dian pontine infarct possibly caused by the occlusion of a penetrat‐
ing artery by a thrombus located in the dolichoectatic basilar artery; 
one had a stroke due to multiple ischemic lesions in the bulbopon‐
tine junction and right frontotemporal white matter; two had a la‐
cunar stroke related to small infarcts in the centrum semiovale; and 
one had a right temporal lobe hemorrhage of undetermined cause.
All IADE patients had white matter hyperintensities and enlarged 
perivascular spaces, five had at least one lacune, and six had at least 
one microbleed; a variable grade of global cortical atrophy was de‐
tected in six patients (Figure 1B‐H and Table 2). Among non‐IADE 
patients, the assessment of neuroimaging SVD features was per‐
formed in 241/244 cases (images were not available for three pa‐
tients) and showed a SVD prevalence of 76.3%.
Considering systemic circulation, six IADE patients had ectasia of 
at least one artery, while one did not have any other enlarged artery 
(Figures 2 and 3); all patients had atherosclerotic intimal thickening 
involving at least one arterial district, while two had stenosis or ob‐
struction of at least one extracranial artery.
The neuropsychological examination revealed normal cognitive 
performances in all the investigated domains for two IADE patients 
and a variable grade of multidomain cognitive impairment for five 
(Table 3). Among the investigated domains, psychomotor speed, ex‐
ecutive functions, and attention were the most frequently involved, 
with a partial preservation of long‐term and especially short‐term 
memory. No significant language dysfunctions emerged.
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Regarding the genetic assessment, the NOTCH3 gene sequenc‐
ing did not lead to the identification of known pathogenic mutations 
responsible for CADASIL in the IADE sample. The GLA gene analysis 
did not highlight pathogenic mutations in the female patient, while 
the assay of the alpha‐galactosidase activity was found within nor‐
mal limits in the six males.
F I G U R E  1   Brain MR angiography and MRI findings in the IADE sample. (A) Gadolinium MR angiography showing basilar artery 
dolichoectasia (arrow) in Patient 2. (B, C, D, and E) Axial fluid‐attenuated inversion recovery (FLAIR) MRI showing enlarged basilar artery (B; 
arrowhead) in Patient 4, deep and periventricular white matter hyperintensities (C and D; asterisk) in Patients 7 and 1, and lacunes (E; arrow) 
in Patient 4. (F) Axial T1‐weighted MRI showing enlarged perivascular spaces in the basal ganglia (arrow) in Patient 2. (G) Axial T2‐weighted 
gradient‐echo (GE) MRI showing deep and lobar cerebral microbleeds (arrows) in Patient 3. (H) Coronal T1‐weighted magnetization‐prepared 
rapid gradient‐echo (MPRAGE) MRI showing global cortical atrophy in Patient 6
(A) B (C) (D)
(E) (F) (G) H(H)
*
*
(B)
F I G U R E  2   Arterial ectasia distribution for anatomical district in the IADE sample. Left panel: detailed representation of the brain arterial 
tree, highlighting vascular ectasia and dolichoectasia side and location. Right panel: detailed representation of the systemic arterial tree, 
highlighting vascular ectasia side and location. Based on the model of Stergiopulos et al33, n indicates number of patients
Middle cerebral artery
(bilateral, n = 1)
Carod siphon
(bilateral,n = 2)
Basilar artery (n = 7)
Ascending aorta (n = 3)
Aorc bulb (n = 2)
Descending aorta (n = 1)
Suprarenal abdominal
aorta (n = 1)
Superficial femoral
artery (right, n = 1)
Common iliac artery
(right, n = 1; bilateral, n = 2)
Subrenal abdominal
aorta (n = 5)
Common coronary
trunk (n = 1)
Anterior descending
coronary artery (n = 1)
Aorc arch (n = 2)
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4  | DISCUSSION
In our series, we made a diagnosis of IADE in 2.8% of the total number 
of screened patients in the reference period. This finding is quite in 
line with the estimate of IADE prevalence in the general population. 
Patients with IADE had a mean age of about 69 years, were more fre‐
quently males, and all had hypertension. A high frequency of older age, 
male sex, and a history of hypertension was noted in IADE patients in 
other series without control groups.17‐20 In this regard, in the GENIC 
Study, a significant positive association emerged between IADE and 
Characteristics
IADE patients 
n = 7
Non‐IADE patients 
n = 244
Age, mean ± SD 68.8 ± 7.2 70.6 ± 13.4
Male sex, n (%) 6 (85.7) 135 (55.3)
Hypertension, n (%) 6 (85.7) 179 (73.4)
Diabetes mellitus, n (%) 1 (14.3) 42 (17.2)
Hypercholesterolemia, n (%) 3 (42.9) 148 (60.6)
Current smokers, n (%) 0 (0) 26 (10.7)
Familiar history of stroke, n (%) 2 (28.6) 67 (27.5)
Personal history of stroke, n (%) 5 (71.4) 112 (45.9)
Personal history of myocardial infarct, n 
(%)
2 (28.6) 24 (9.8)
IADE, intracranial arterial dolichoectasia; SD, standard deviation; n, number of patients.
TA B L E  1   Demographic characteristics 
and vascular risk factor profile in IADE 
and non‐IADE patients
Variables
Patient
1 2 3 4 5 6 7
IADE
Basilar artery, diameter (mm) 5.9 15.5 6.8 5.8 4.9 4.7 4.8
Anterior circulation involvement N Y N Y N N N
White matter hyperintensities 
(grade)a
3 1 2 3 2 2 3
Lacunes (number) >3 >3 1‐3 >3 >3 0 0
Enlarged perivascular spaces (grade)b
Basal ganglia 4 2 2 1 2 3 1
Centrum semiovale 4 0 0 0 0 0 0
Total 8/8 2/8 2/8 1/8 2/8 3/8 1/8
Midbrain 1 0 1 1 0 0 0
Hippocampus 1 0 1 1 1 1 1
Cerebral microbleeds (number)c
Definite
Lobar 1 0 11 1 2 1 0
Deep 1 0 16 2 0 1 5
Subtentorial 0 0 10 0 0 0 0
Possible
Lobar 1 0 8 0 6 0 0
Deep 1 0 5 2 0 0 2
Subtentorial 0 0 4 0 0 0 0
Global cortical atrophy (grade)d 3 1 2 2 2 2 0
IADE, intracranial arterial dolichoectasia; Y, yes; N, no.
aAssessed with the modified Fazekas scale. 
bAssessed with the 5‐point scale by Doubal et al 
cAssessed with the Microbleed Anatomical Rating Scale. 
dAssessed with the Pasquier scale. 
TA B L E  2   Brain MR angiography and 
MRI findings in the IADE sample
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older age, male sex, and hypertension,3 suggesting a role of these fac‐
tors in the pathogenesis of the dolichoectatic process.1 Other tradi‐
tional factors such as increased body mass index, cigarette smoking, 
dyslipidemia, and diabetes mellitus show conflicting results.3,21,22
The dolichoectatic process affected the posterior circulation 
alone in five patients and both the posterior and anterior circulation 
in two patients. In the GENIC Study, IADE involved the posterior 
circulation (alone or in combination with the anterior circulation) 
in 87% of cases, while the basilar artery resulted dolichoectatic in 
78% of patients.3 In another case‐control study conducted on 387 
patients with brain infarct in which CT scan was the main imaging 
method, the dolichoectatic process involved the posterior circula‐
tion in 83% of IADE patients.23
We reported a relevant presence of cerebral SVD features in 
our sample. In line with the GENIC Study results,4 our patients 
with IADE more often had SVD features than patients without. 
In a recent MRI‐based study, basilar artery dolichoectasia was 
associated with both white matter hyperintensities and cerebral 
microbleeds.24 Similarly, in a series of 187 patients hospitalized 
because of ischemic stroke or transient ischemic attack, mi‐
crobleeds were more prevalent in stroke patients with IADE than 
in those without, especially in the posterior circulation territory.25 
Regarding the hypothesized association between IADE and ce‐
rebral SVD, some considerations can be put forward. First, our 
data suggest that IADE and SVD may share some undetermined 
risk factors (environmental and/or genetic). Supposed interac‐
tions between common vascular risk factors and a predisposing 
genotype might impair the matrix metalloproteinase balance in 
the tunica media contributing to IADE pathophysiology, similarly 
to what is observed in SVD.26,27 Second, IADE and SVD could be 
F I G U R E  3   Whole‐body CT 
angiography findings in the IADE sample. 
(A) 3D reconstruction CT angiography 
showing ascending aorta, aortic arch, and 
abdominal aorta ectasia (arrows) in Patient 
2. (B) CT angiography (frontal view): detail 
of aortic bulb (asterisk), ascending aorta, 
and aortic arch ectasia (arrow) in Patient 3
*
(A) (B)
TA B L E  3   Neuropsychological assessment in the IADE sample
Variables Patient‐adjusted scores
Cognitive domain Test Range 1 2 3 4 5 6 7
Global mental 
functioning
Mini‐Mental State 
Examination
0‐30 20.3a 30.0 25.8 27.5 29.0 28.9 28.5
Memory Rey Auditory‐Verbal Learning 
Test (immediate recall)
0‐75 28.0a 40.5 39.3 26.9a 29.0 33.3 45.2
Rey Auditory‐Verbal Learning 
Test (delayed recall)
0‐15 3.4a 7.3 8.5 2.5a 5.2 4.3a 10.0
Attention and executive 
functions
Trail Making Test, Part A Time (s) 53.3 16.7 110.4a 108.7a 6.4 101.8a 53.3
Trail Making Test, Part B Time (s) >300a 95.8 >300a >300a >300a >300a 105.4
Visual search 0‐50 23.8a 41.8 28.4 10.7a 40.1 33.4 39.7
Symbol Digit Modalities Test Targets in 90 s 31.2a 39.7 21.6a NE 36.9 31.4a 36.0
Color Word Stroop Test Time (s) 175.2a 19.3 28.6 26.9 25.4 13.5 23.2
Language Phonemic verbal fluency Words in 3 min 16.6 46.0 19.3 20.1 26.2 26.0 19.9
Semantic verbal fluency Words in 3 min 24.8 48.1 25.6 25.4 36.1 28.7 36.6
Raw scores were adjusted according to normative data on healthy Italian adult samples.
NE, not evaluable.
aAbnormal performance, that is, lower than the 5th percentile of the normal population. 
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different phenotypic expression of the same pathophysiological 
mechanisms, respectively involving macro‐ and microvessels. The 
hypothesis that the dolichoectatic process may also affect the 
small vessels of the brain was first suggested in a post‐mortem 
MRI‐based study in which all areas with myelin staining pallor, cor‐
responding to MRI white matter hyperintensities, showed a spec‐
trum of alterations ranging from arteriosclerosis to ectasia of small 
perforating arteries and veins.28
In our series, the majority of patients exhibited ectasia of at least 
one extracranial artery. The thoracoabdominal was the most fre‐
quently involved district. To the best of our knowledge, this is the first 
prospective study thoroughly investigating the correlation between 
IADE and systemic arteriopathy by means of whole‐body CT angiog‐
raphy. However, the reported findings are not of univocal interpre‐
tation from a pathogenic point of view and need to be confirmed in 
larger patient series. One autopsy study based on 34 IADE patients 
found an abdominal aortic aneurysm in 12 cases but, as in our study, 
there was no control group.29 Other uncontrolled studies on IADE 
patients that used autopsy and angiography material have occasion‐
ally found some arterial abnormalities, such as saccular intracranial 
aneurysms, dolichoectasia of the cervical arteries, and iliac arteries 
aneurysms.17,18,29 In a substudy of the GENIC, there was a clear asso‐
ciation between IADE and diameter of the descending thoracic aorta 
measured by transesophageal echocardiography.5 Furthermore, the 
GENIC investigators found that in a large autopsy series based on 
stroke patients, there was a significant association between IADE and 
coronary artery ectasia.6 Fragmentation of the internal elastic lamina 
caused by increased plasma concentrations of some metalloprotein‐
ases and/or decreased concentrations of their inhibitors has been re‐
ported in patients with either abdominal aortic aneurysms or IADE.26 
Likewise, a proteolytic imbalance induced by specific metalloprotein‐
ase polymorphisms has also been related to the development of tho‐
racic aorta dissection and coronary artery ectasia.30,31
In our patients, the presence of intimal thickening and plaques 
with or without stenoses likely reflects the coexistence of IADE and 
systemic atherosclerosis. In the past, due to the fact that IADE and 
atherosclerosis share similar risk factors, these disorders were pos‐
tulated to have a common pathogenesis. Although the preferential 
development of atherosclerotic plaques in response to hemody‐
namic changes induced by dolichoectasia reinforced the assumption 
of IADE as a severe form of atherosclerosis, further investigations 
definitively pointed out different pathophysiological pathways.2 
Whereas IADE involves disruption of the elastic tissue of the tunica 
media and of the internal elastic lamina, atherosclerosis involves ox‐
idized lipid infiltration and inflammation of the vascular wall intima.1 
In the GENIC Study, the lack of any association between IADE and 
several ultrasonographic markers of atherosclerosis such as common 
carotid arteries intima‐media thickness and carotid plaques corrob‐
orated on clinical grounds the hypothesis that IADE is not an ectatic 
variant of atherothrombotic disease.3
We recorded a high prevalence of neuropsychological deficits in 
our small series. From our data, it is not possible to establish whether 
this finding is more related with the disease of the large arteries or 
with the almost invariably associated cerebral SVD. While various 
biomarkers of SVD have been put in relationship with cognitive im‐
pairment, some recent data seem to support also the association 
between larger brain arterial diameter and lower performances on 
neuropsychological tests regardless the occurrence of major vascu‐
lar events.32
This study has limitations. First, the nature of the study is uncon‐
trolled, and therefore, it is not possible to draw definitive conclu‐
sions about IADE and its association with cerebral SVD and systemic 
arteriopathy. Second, the sample size is limited in number and lacks 
of heterogeneity, being composed by “somehow selected” patients 
with a high frequency of sporadic or familiar forms of cerebral 
microangiopathy.
With the above‐mentioned limitations in mind, our data seem to 
support however that in patients with IADE, the study of systemic 
vessels and cognitive profile is warranted. For the first one, the use 
of recent CT protocols and machines can allow the examination to 
be performed in only one session and reduce the amount of infused 
contrast medium. Concerning the second, our study reinforces the 
idea that neuropsychological testing should be performed systemat‐
ically in patients with cerebrovascular diseases also in the absence of 
overt stroke. Future studies performed with larger sample will allow 
to assess whether the neuropsychological deficits found in IADE are 
more related to the larger arterial diameter or the coexistence of 
cerebral SVD.
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